Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Feb 23, 2017
    Alleged Disease Claims, Labeling and cGMP Violations Lead to Shutdown of Dietary Supplement Maker
  • Feb 21, 2017
    ERSP Finds Firm Can Support Supplement Claims After Voluntarily Discontinuing Other Claims
  • Feb 21, 2017
    Survey Suggests Alternatives to DTC Ads
  • Feb 20, 2017
    CDER Has No Plans To Issue Advertising Guidance in 2017
  • Feb 20, 2017
    Oregon Bill Requires Justification Report on High Price Drugs
  • Feb 17, 2017
    Trade Groups Petition FDA To Reconsider ‘Intended Use’ Regulation Amendment
  • Feb 15, 2017
    APLB Cites Slide Set for Omitting Risks
  • Feb 14, 2017
    NAD Recommends Curcumin Dietary Supplement Maker Discontinue Challenged Advertising Claims
  • Feb 14, 2017
    Former Insys Sales Manager Indicted on Conspiracy Charge for Alleged Kickback Scheme
  • Feb 13, 2017
    California Dietary Supplement Manufacturer Is Shut Down Under Terms of FDA Consent Decree
  • More

Good Clinical Practice

  • Aug 31, 2017
    FDA Issues Alert After Deaths in Keytruda Trial
  • Aug 28, 2017
    Appeals Court Upholds Martoma Conviction in Split Decision
  • Aug 25, 2017
    OIG Finds EPA Needs More Human Research Guidance
  • Aug 25, 2017
    Researchers Tout Trial Simulations
  • Aug 25, 2017
    CTTI Provides Recommendations, Web Tool for Determining Pregnancy Testing in Clinical Trials
  • Aug 24, 2017
    Number of FDA BIMO Inspections Drop Nearly 10 Percent in FY 2016
  • Aug 24, 2017
    BMC Medicine Will Use Registered Reports
  • Aug 24, 2017
    Working Group Details 2016 European GCP Inspections
  • Aug 21, 2017
    FDA Reauthorization Act Includes Clinical Trial Provisions
  • Aug 18, 2017
    Review Finds UK Universities Not Reporting Clinical Trial Results
  • More

U.S. Food Labeling

  • May 31,2011
    Sales of Organically Labeled Products Continue To Show Strong Growth in U.S. Market
  • May 31,2011
    New COOL Bill for Dairy Introduced in Senate
  • May 31,2011
    FDA Urged To Crack Down on Tomato Products' Labels
  • May 31,2011
    Lawsuit Targets Bayer's Probiotic Supplements
  • Apr 30,2011
    Guidance for Industry Helps FDA (Mostly) Win First Amendment Case on Health Claims
  • Apr 30,2011
    Sprouts Company Gets Warning Letter for Making Therapeutic Claims on Website
  • Apr 30,2011
    Marketing Firms Picked for $50 Mil. FOP Campaign
  • Apr 30,2011
    Proposed Rule on Menu Labeling Exempts Movie Theatres But Grocery Stores Are Left Guessing
  • Apr 30,2011
    FDA Advisory Panel Votes Not To Require Warning Labels for Artificial Dyes in Foods
  • Apr 30,2011
    Product Recalls
  • More

FDA Regulation & Enforcement

  • Jan 19, 2020
    Endo Settles with Oklahoma Over Opioid Marketing
  • Jan 17, 2020
    Sleep Apnea DME Manufacturer To Pay More than $37.5 Million To Resolve Kickback Allegations
  • Jan 16, 2020
    FDA Finalizes New Food Labeling Serving Size Guidance
  • Jan 15, 2020
    Former Insys Executive Sentenced to 33 Months in Prison for Role in Prior Authorization Scheme
  • Jan 14, 2020
    FDA Revises Procedures for Drug Preapproval Inspections To Outline Collaboration by ORA, CDER Staff
  • Jan 9, 2020
    Consent Decree Shuts Down New York-Based Dietary Supplement Manufacturer After Repeated cGMP Violations
  • Jan 8, 2020
    Teva Agrees To Pay $54 Million To Settle Qui Tam Case Involving Speaker Program Allegations
  • Jan 7, 2020
    Marketers Need New Mindsets, Skillsets and Toolkits
  • Jan 4, 2020
    Washington State Sues J&J Over Janssen Opioid Marketing
  • Dec 31, 2019
    NAD Refers Device Ad Claims to FDA, FTC
  • More

Medical Devices

  • Jan 24, 2014
    New Draft Guidance From CDRH Addresses Use of Animal-derived Material in Device Manufacturing
  • Jan 21, 2014
    Physician Pleads Guilty to Lying to Grand Jury in Connection With Orthofix Reimbursement Scheme
  • Jan 17, 2014
    FDA Offers Draft Guidance on How To Report Computational Modeling Studies in Device Submissions
  • Jan 15, 2014
    Draft Guidance Interprets FDASIA Provision on Custom Devices, Proposes Annual Report Guidelines
  • Jan 14, 2014
    FDA Issues Final Rule on Pediatric Information Needed for Device Applications
  • Jan 9, 2014
    FDA Database Changes Address 510(k) Safety Issues, Allow Access to Info on Predicates' Recalls
  • Jan 7, 2014
    CDRH, ORA Pilot Program To Foster Identification, Correction of Problems by Device Manufacturers
  • Dec 31, 2013
    CDRH OC Reorganization Stresses Compliance Activities Over Individual Products, Director Says
  • Dec 31, 2013
    Abbott Settles False Claims Act Charges for $5.475 Million; Kickbacks, Off-label Sales Alleged
  • Dec 17, 2013
    Sterilization Monitoring Device Manufacturer Settles Dispute With FDA Over Product Expiration Dates
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.